Granules India
GRANULES
Granules India Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | - | 24,05,849 |
| Weekly | 12.41% | 64,46,423 |
| Monthly | 13.22% | 2,10,01,158 |
Granules India Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| GRANULES | - | 12.41% | 13.22% |
| Index | - | - | - |
| Peer Avg. | - | 5.43% | 11.51% |
Granules India Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| GRANULES | 19.03 | 2.99 | 9.77 | 17.02 | 16.83 | 0.47 |
| Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
| Peer Avg. | 39.55 | 4.75 | 12.35 | 13.59 | 17.02 | 0.87 |
Granules India Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | 9.79% | -27.48% | 17.02% | 16.83% |
| FY '20-21 | 30.15% | 50.89% | 27.79% | 25.98% |
| FY '19-20 | 12.05% | 119.76% | 23.06% | 19.94% |
Granules India Shareholding Pattern
Granules India Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 3,501.68 | 2,818.85 | 701 | 399.64 |
| FY '20-21 | 3,186.26 | 2,327.96 | 878.60 | 551.12 |
| FY '19-20 | 2,454.29 | 1,944.56 | 541.23 | 376.99 |
Granules India Share Price
Granules India Limited is an Indian pharmaceutical manufacturer. The company operates through the pharmaceutical segment. Its geographical segments include India and non-India. The company is present in the entire value chain of pharmaceutical manufacturing, including active ingredients (API), pharmaceutical formulation intermediates (PFI) and finished dosage forms (FD). It has more than eight manufacturing units, of which about seven are located in India and one in the United States. The company sells its products in global markets, including the United States, Canada, Latin America, Europe, Asia and India. The Company's wholly owned subsidiaries are Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.